Skip to main content
OpenTrials

Clinical trial condition

Advanced Non-Small Cell Lung Cancer

Explore clinical trials studying Advanced Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Advanced Non-Small Cell Lung Cancer trial results

Active, Not Recruiting

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

NCT05607550

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Arrivent Investigative Site Daphne, Alabama, United States
  • Arrivent Investigative Site Yuma, Arizona, United States
  • Arrivent Investigative Site Fayetteville, Arkansas, United States
  • Arrivent Investigative Site Beverly Hills, California, United States
View all 208 locations
View Trial Details

Related conditions